Rawshani, A. and others Mortality and cardiovascular disease in type 1 and type 2 diabetes. N. Engl. J. Med. 376(15), 1407–1418 (2017).
TranDuy, A. and others A patient-level model for estimating the lifetime health outcomes of patients with type 1 diabetes. diabetes care 43(8), 1741–1749 (2020).
Rawshani, A. and others Excess mortality and cardiovascular disease in young adults with type 1 diabetes relative to age of onset: a national registry-based cohort study. Lancet London. English 392(10146), 477–486 (2018).
Holman, N. and others Comparison of mortality in people with type 1 and type 2 diabetes by age at diagnosis: a population-based incident study in England and Wales. Lancet Diabetes Endocrinol. 10(2), 95–97 (2022).
Kristo, R. and others Burden of cardiovascular and renal disease in type 1 diabetes compared with type 2 diabetes: two countries. diabetes care 448 (2021).
Nathan, DM The Diabetes Control and Complications Study/Epidemiology of Diabetes Interventions and Complications at Age 30: Overview. diabetes care 37(1), 9–16 (2014).
Lindo, m. and others The relationship between glycemic control and heart failure in 83,021 patients with type 2 diabetes. Diabetes 55(11), 2946–2953 (2012).
Banerjee, S. & Panas, R. Diabetes and cardiorenal syndrome: Understanding the “Triple Threat”. Hellenic J. Cardiol. 58(5), 342–347 (2017).
Cardiorenal Syndrome: Classification, Pathophysiology, Diagnosis, and Treatment Strategies: An American Heart Association Scientific Statement (Internet). (Cited February 4, 2022). https://doi.org/10.1161/CIR.0000000000000664.
Lindo, m. and others Glycemic control and excess mortality in type 1 diabetes. N. Engl. J. Med. 371(21), 1972–1982 (2014).
Edqvist, J. and others Trajectories in HbA1c and other risk factors among adults with type 1 diabetes by age of onset. BMJ Open Diabetes Res. Caution. 9(1), e002187 (2021).
TD Control, D CTDE Interventions, Complications (EDIC) Study Research Group. Intensive diabetes care and cardiovascular outcomes in type 1 diabetes: the 30-year follow-up DCCT/EDIC study. 2016;39(5):686–93.
Secrest AM, Becker DJ, Kelsey SF, Laporte RE & Orchard TJ Cause-specific mortality trends in a large population cohort with longstanding childhood-onset type 1 diabetes. Diabetes 59(12), 3216–3222 (2010).
Patterson, CC and others Trends and cyclical variation in the incidence of childhood type 1 diabetes in 26 European centers over the 25-year period 1989 to 2013: a multicentre prospective registry study. Diabetes 62(3), 408–417 (2019).
Norris, JM, Johnson, RK & Stene, LC Type 1 diabetes – Origins in early childhood and changes in epidemiology. Lancet Diabetes Endocrinol. 8(3), 226–238 (2020).
Heve, J. and others Incidence of end-stage renal disease in patients with type 1 diabetes. diabetes care 41(3), 434–439 (2017).
Columbus, M. and others Predicting kidney disease progression in a large contemporary cohort with type 1 diabetes mellitus. Diabetes 63(3), 636–647 (2020).
Eliasson, B. & Gudbjörnsdottir, S. Diabetes care–Improvement through measurement. Res. of Diabetes Clin. Practice. 106(Suppl 2), S291–S294 (2014).
Ludvigsson, JF and others External review and validation of the Swedish national inpatient registry. BMC Public Health 11(1), 450 (2011).
Brooke, HL and others The Swedish registry of causes of death. EUR. J. Epidemiology. 32(9), 765–773 (2017).
Wettermark, B. and others The new Swedish Register of Prescription Medicines – opportunities for pharmacoepidemiological research and experience from the first six months. Pharmacoepidemiol. Damn Mon. 16(7), 726–735 (2007).
Ludvigsson, JF, Svedberg, P., Olén, O., Bruze, G. & Neovius, M. The longitudinal integrated database for health insurance and labor market studies (LISA) and its use in medical research. EUR. J. Epidemiology. 34(4), 423–437 (2019).
Levey, AS and others Using standardized values of serum creatinine in diet modification in the kidney disease study equation to estimate glomerular filtration rate. A-N-A. Internal. With. 145(4), 247–254 (2006).
Stevens, PE & Levin, A. Kidney Disease: Improving Global Outcomes Guideline for Developing Chronic Kidney Disease Guidelines Working Group Members Assessment and Treatment of Chronic Kidney Disease: Kidney Disease Synopsis: Improving Global Outcomes 2012 Clinical Practice Guideline. Ann Intern Med. 158(11), 825–830 (2013).
Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. In papers3://publication/uuid/CE199FF3-D5B1–4B66-A8AB-4861DEE9A3C1, 1615–25 (2005).
Harcourt BE, Penfold SA & Forbes JM Coming full circle in diabetes mellitus: from complications to onset. Nat. Rev. Endocrinol. 9(2), 113–123 (2013).
Lind, M., Svensson, AM & Rosengren, A. Glycemic control and excess mortality in type 1 diabetes. N. Engl. J. Med. 372(9), 880–881 (2015).
Rawshani, A. and others Relative prognostic importance and optimal levels of risk factors for mortality and cardiovascular outcomes in type 1 diabetes mellitus. Circulation 139(16), 1900–1912 (2019).
Andersen AR, Christiansen JS, Andersen JK, Kreiner S. & Deckert T. Diabetic nephropathy in type 1 (insulin-dependent) diabetes: an epidemiologic study. Diabetes 25(6), 496-501 (1983).
Pomar, TJ and others Association between seven years of intensive type 1 diabetes treatment and long-term mortality. JAMA 313(1), 45–53 (2015).
Groop, PH and others The presence and severity of chronic kidney disease predict all-cause mortality in type 1 diabetes. Diabetes 58(7), 1651–1658 (2009).
Orchard, TJ & Costacou, T. Cardiovascular complications of type 1 diabetes: an update on the renal link. Diabetes Law. 54(4), 325–334 (2017).
Schefold JC, Filippatos G, Hasenfuss G, Anker SD & von Haehling S. Heart failure and renal dysfunction: epidemiology, mechanisms and treatment. Nat. Rev. Nephrol. 12(10), 610–623 (2016).
Vesberg, D. and others Decreased eGFR as a risk factor for heart failure in 13,781 subjects with type 1 diabetes. J. Diabetes Sci. Technol. 10(1), 131–136 (2015).
11. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes — 2022 | Diabetes Care | American Diabetes Association (Internet). (cited April 22, 2022). Available from: https://diabetesjournals.org/care/article/45/Supplement_1/S175/138914/11-Chronic-Kidney-Disease-and-Risk-Management.
Navaneethan, SD and others Management of diabetes in chronic kidney disease: synopsis of the KDIGO 2020 clinical practice guideline. A-N-A. Internal medicine. 174(3), 385–394 (2021).
DiAngelantonio, E. and others Body mass index and all-cause mortality: meta-analysis of data from individual participants from 239 prospective studies on four continents. Lancet 388(10046), 776–786 (2016).
Lim NK, Park HY, Kim WH, Mancia G. & Cho MC The U-shaped association between achieved blood pressure and risk of cardiovascular events and mortality in elderly and young patients. J. Hypertensive. 38(8), 1559–1566 (2020).
Wang, Y. and others Sex differences in the association between diabetes and risk of cardiovascular disease, cancer, and all-cause and cause-specific mortality: a systematic review and meta-analysis of 5,162,654 participants. BMC Med. 17(1), 136 (2019).